Compliance News Archive

Safety of supplements pulls prosecutors together  (NY Times)

Group asks for more information on supplement labels (Raps.org)

Is GHRP the new supplement adulterant to look out for? (Nutritional Outlook)

Was NY AG testing of supplements inadequate? (Forbes.com)

FDA warns of viagra, sibutramine in supplements (Cleveland.com)

Global supplement market to reach $80B by 2020 from $60B in 2014 (FMI)

DNA Testing adequate for raw botanicals, not extracts – Blumenthal (Natural Products Insider)

Industry demands NY Attorney General to release the report (Natural Products Insider)

Council for Responsible Nutrition sends formal request to NY Attorney General to release data (Nutraingredients-USA)

Extracts: More than a Cup of Tea (Natural Products Insider)

GNC: Tests and retests refute NY AG claims (Nutraingredients-USA)

Industry experts respond to NY AG actions (Nutraingredients-USA)

10 questions NY Attorney General should answer (Nutraingredients-USA)

What’s In Those Supplements? (NY Times)

USP: With new years resolutions, keep an eye on supplement quality (PR Web)

Years after law, GMP compliance still a challenge for many (Natural Products Insider)

Organolepsis OK? FDA ID requirements for botanicals may vary (Nutraingredients-USA)

American Botanical Council offers skullcap laboratory guidance in response to adulteration concerns

UNPA founder: 2015 will reflect ‘growing void’ between GMP-compliant and non-compliant companies resulting in ‘ongoing cascade’ of warning letters (Nutraingredients-USA)

Case of supplement contamination raises new questions about probiotic quality control (Nutraingredients-USA)

Supplement GMP compliance expected among top industry influences in 2015 (Nutraingredients-USA)

Requirements for marketers beyond the batch record (Natural Products Insider)

Vermont herbal distributor handed FDA warning letter for lack of GMP documentation (Burlington Free Press)